Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK) Stock Gets Price Target Cut from UBS Group

Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK) had its price target decreased by analysts at UBS Group from $75.00 to $71.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. UBS Group’s price target points to a potential upside of 17.23% from the stock’s current price.

VMRK has been the subject of several other research reports. Wells Fargo & Company began coverage on shares of Vivmark Residential Common Shares of Beneficial Interest in a report on Friday, August 21st. They set an “overweight” rating and a $72.00 price objective for the company. Stifel Nicolaus cut their target price on shares of Vivmark Residential Common Shares of Beneficial Interest from $79.00 to $78.50 and set a “buy” rating for the company in a research note on Wednesday, August 19th. Cantor Fitzgerald reissued a “neutral” rating and issued a $70.00 target price on shares of Vivmark Residential Common Shares of Beneficial Interest in a report on Tuesday, August 25th. Piper Sandler decreased their price target on Vivmark Residential Common Shares of Beneficial Interest from $76.00 to $67.00 and set a “neutral” rating on the stock in a research report on Monday. Finally, BMO Capital Markets decreased their price target on Vivmark Residential Common Shares of Beneficial Interest from $75.00 to $74.00 and set a “market perform” rating on the stock in a research report on Monday, August 24th. Five research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat.com, Vivmark Residential Common Shares of Beneficial Interest currently has a consensus rating of “Hold” and a consensus price target of $71.73.

Vivmark Residential Common Shares of Beneficial Interest Trading Down 1.0%

Shares of Vivmark Residential Common Shares of Beneficial Interest stock traded down $0.63 during mid-day trading on Wednesday, reaching $60.57. 675,876 shares of the stock were exchanged, compared to its average volume of 3,533,341. Vivmark Residential Common Shares of Beneficial Interest has a fifty-two week low of $57.57 and a fifty-two week high of $71.50. The stock has a market capitalization of $22.71 billion, a P/E ratio of 26.36, a price-to-earnings-growth ratio of 3.55 and a beta of 0.74. The company has a quick ratio of 0.19, a current ratio of 0.19 and a debt-to-equity ratio of 0.77.

Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK) last released its quarterly earnings results on Wednesday, July 22nd. The company reported $0.30 EPS for the quarter. The firm had revenue of $785.05 million for the quarter. Vivmark Residential Common Shares of Beneficial Interest had a net margin of 27.97% and a return on equity of 8.06%. Research analysts expect that Vivmark Residential Common Shares of Beneficial Interest will post 4.07 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Chris Carr sold 1,130 shares of the firm’s stock in a transaction on Wednesday, September 9th. The shares were sold at an average price of $65.28, for a total value of $73,766.40. Following the completion of the transaction, the director directly owned 4,461 shares of the company’s stock, valued at approximately $291,214.08. This trade represents a 20.21% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Susan Swanezy sold 15,700 shares of the business’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $63.80, for a total transaction of $1,001,660.00. Following the transaction, the director owned 28,934 shares in the company, valued at approximately $1,845,989.20. The trade was a 35.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 58,286 shares of company stock worth $3,735,822 in the last ninety days. 1.20% of the stock is owned by insiders.

Hedge Funds Weigh In On Vivmark Residential Common Shares of Beneficial Interest

Institutional investors have recently bought and sold shares of the business. Planning Strategies Inc. boosted its stake in shares of Vivmark Residential Common Shares of Beneficial Interest by 87.5% during the 3rd quarter. Planning Strategies Inc. now owns 538 shares of the company’s stock worth $33,000 after acquiring an additional 251 shares during the period. First Financial Corp IN bought a new stake in Vivmark Residential Common Shares of Beneficial Interest in the 3rd quarter valued at $42,000. American National Bank & Trust acquired a new stake in Vivmark Residential Common Shares of Beneficial Interest during the 3rd quarter valued at $69,000. Tompkins Financial Corp acquired a new stake in Vivmark Residential Common Shares of Beneficial Interest during the 3rd quarter valued at $76,000. Finally, Rosenberg Matthew Hamilton lifted its holdings in Vivmark Residential Common Shares of Beneficial Interest by 47.8% during the 3rd quarter. Rosenberg Matthew Hamilton now owns 1,301 shares of the company’s stock valued at $79,000 after purchasing an additional 421 shares during the last quarter. Institutional investors and hedge funds own 92.68% of the company’s stock.

Vivmark Residential Common Shares of Beneficial Interest Company Profile

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, DC, Seattle, San Francisco, Southern California and Denver.